Citric acid 75 mg/ML / magnesium oxide 21.9 mg/ML / picosulfate sodium 0.0625 mg/ML [Clenpiq]
RxNorm 1994541

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1994541 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: citric acid 75 mg/ML / magnesium oxide 21.9 mg/ML / picosulfate sodium 0.0625 mg/ML [Clenpiq].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDC
Citric acid 75 mg/ML / magnesium oxide 21.9 mg/ML / picosulfate sodium 0.0625 mg/ML [Clenpiq]
AUI:12303971
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDCPrescribable

Semantic Branded Drug Component (SBDC):
Citric acid 75 mg/ML / magnesium oxide 21.9 mg/ML / picosulfate sodium 0.0625 mg/ML [Clenpiq]
(Atom ID: 12303971)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
citric acid 75 MG/ML / magnesium oxide 21.9 MG/ML / picosulfate sodium 0.0625 MG/ML [Clenpiq]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1994541
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12303971
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDC
Semantic Branded Drug Component (Ingredient + Strength + Brand Name)
Source Code
1994541
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid


Sodium picosulfate, magnesium oxide, and anhydrous citric acid is used in adults and children 9 years of age and older to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check for colon cancer and other abnormalities) so that the doctor will have a clear view of the walls of the colon. Sodium picosulfate is in a class of medications called stimulant laxatives. Magnesium oxide and anhydrous citric acid combine to form a medication called magnesium citrate. Magnesium citrate is in a class of medications called osmotic laxatives. These medications work by causing watery diarrhea so that the stool can be emptied from the colon.
[Learn More]


Magnesium



[Learn More]


* Please review the disclaimer below.